A new flavonoid glycoside from Tapinanthus sp. (Loranthaceae) and evaluation of anticancer activity of extract and some isolated compounds

Nat Prod Res. 2022 Aug;36(16):4085-4093. doi: 10.1080/14786419.2021.1963243. Epub 2021 Aug 12.

Abstract

The present work describes the isolation and anticancer activity of Tapinanthus sp. which is a hemi parasitic plant harvested on Combretum glutinosum, the host plant. Phytochemical study afforded a new flavonoid glycoside, tapinantoside (1) isolated for the first time from natural source, alongside six known compounds (2-7). Structure of compounds were elucidated by extensive spectroscopic analyses including 1 D and 2 D NMR, mass spectrometry and by comparison with literature data. The anticancer activity of extract and some isolated compounds were evaluated on glioblastoma (U87MG, C6) and prostate (PC-3) cancer cells. The methanol leaves extract showed good anticancer activity against U87 (IC50 = 21.40 µg/mL) and PC-3 cells (IC50 = 10.26 µg/mL). Compound 3 powerfully inhibits the proliferation of C6 (IC50 = 38.84 µM) and PC-3 cells (IC50 = 21.33 µM), while its effect was moderated on U87MG cells. Compound 1 and 7 were not active on all tested cancer cell lines.

Keywords: Tapinanthus sp.; anticancer activity; flavonoid glycoside; tapinantoside.

MeSH terms

  • Cardiac Glycosides*
  • Flavonoids / chemistry
  • Flavonoids / pharmacology
  • Glycosides / pharmacology
  • Loranthaceae*
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • Plant Leaves

Substances

  • Cardiac Glycosides
  • Flavonoids
  • Glycosides
  • Plant Extracts